|
FY2025
12 months to Jan 3, 2026
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided (used) by operating activities: | |||||
| Depreciation | |||||
| Amortization of other intangible assets | |||||
| Provisions for losses on finance receivables | |||||
| Provisions for losses on non-finance receivables | |||||
| Stock-based compensation expense | |||||
| Deferred income tax provision (benefit) | |||||
| Gain on sales of assets | |||||
| Changes in operating assets and liabilities, net of effects of acquisitions: | |||||
| Trade and other accounts receivable | |||||
| Contract receivables | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Additions to finance receivables | |||||
| Collections of finance receivables | |||||
| Capital expenditures | |||||
| Acquisitions of businesses, net of cash acquired | |||||
| Disposals of property and equipment | |||||
| Other | |||||
| Net cash used by investing activities | |||||
| Financing activities: | |||||
| Repayments of long-term debt | |||||
| Net increase (decrease) in other short-term borrowings | |||||
| Cash dividends paid | |||||
| Purchases of treasury stock | |||||
| Proceeds from stock purchase plans and stock option exercises | |||||
| Other | |||||
| Net cash used by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental cash flow disclosures: | |||||
| Cash paid for interest | |||||
| Net cash paid for income taxes | |||||
Loading...
